Systemic side effects from topical imiquimod.
Hanger
Carl
C
Older Persons Health, Princess Margaret Hospital, Christchurch, New Zealand. carl.hanger@cdhb.govt.nz
Dalrymple
Judith
J
Hepburn
David
D
D000287:Administration, Topical; D000368:Aged; D000634:Aminoquinolines / Q000008:administration & dosage* / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001799:Blood Sedimentation / Q000187:drug effects; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D003863:Depression / Q000139:chemically induced; D005153:Facial Neoplasms / Q000188:drug therapy*; D005221:Fatigue / Q000139:chemically induced; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D000077271:Imiquimod; D008297:Male; D016896:Treatment Outcome; D015431:Weight Loss / Q000187:drug effects
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod